Background: The cuff leak test (CLT) is an important tool to assess the risk of upper airway obstruction after extubation.

Research Question: Does modified CLT approach have superior ability in predicting re-intubation compared with traditional method?

Study Design And Methods: This was a prospective, multicenter, randomized control trial. The primary end point was the incidence of the need for reintubation within 48 h after extubation. The secondary end points were the actual incidence of reintubation, the incidence of post-extubation stridor (PES), and the duration of invasive mechanical ventilation (IMV), etc. RESULT: There were totally 536 patients randomized to either modified CLT group (n = 268) or control group (n = 268). The incidence of reintubation within 48 h after extubation did not differ between the groups. PES within 24 h after extubation was more frequent in the modified CLT group than in the control group (5.22% vs. 1.49%; OR 0.275 [95% CI, 0.089-0.846]; P = 0.028). The IMV duration was shorter in the modified CLT group than in the control group (137 h [74, 218] vs. 159 h [95, 252]; OR 1.001 [95% CI, 1.000-1.002], P = 0.046). In the patients with IMV duration ≥6 days, the incidence of PES was 2.95% in modified CLT group and 0.74% in the control group (OR 0.203 [95% CI, 0.042-0.975], P = 0.048).

Interpretation: Compared with the control group, the modified CLT approach might better predict PES within 24 h after extubation, especially for the patients with IMV duration longer than 6 days, but it could not help decrease the reintubation incidence and mortality.

Clinicaltrials: GOV: NCT05550220, Registered 19 September 2022.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2025.01.033DOI Listing

Publication Analysis

Top Keywords

modified clt
24
control group
20
clt group
16
incidence reintubation
12
imv duration
12
group
9
cuff leak
8
leak test
8
invasive mechanical
8
mechanical ventilation
8

Similar Publications

Background: The cuff leak test (CLT) is an important tool to assess the risk of upper airway obstruction after extubation.

Research Question: Does modified CLT approach have superior ability in predicting re-intubation compared with traditional method?

Study Design And Methods: This was a prospective, multicenter, randomized control trial. The primary end point was the incidence of the need for reintubation within 48 h after extubation.

View Article and Find Full Text PDF

Acute kidney injury (AKI) is a dynamic process associated with inflammation, oxidative stress, and lipid peroxidation, in which mitochondrial mitophagy and macrophage polarization play a critical role in the pathophysiology. Based on the expression of the CD44 receptor on renal tubular epithelial cells (RTECs) and activated M1 macrophages being abnormally increased, accompanied by up-regulation of reactive oxygen species (ROS) during AKI, the conjugates of bilirubin (BR), an endogenous antioxidant which has the property of anti-inflammation, and chondroitin sulfate (CS) with CD44-targeting property could be a promising therapeutic carrier. In this study, we develop a CD44-targeted/ROS-responsive CS-BR-mediated multifunctional liposome loading celastrol (CS-BR@CLT) for the targeted therapy of AKI.

View Article and Find Full Text PDF

Background: The widespread use of next-generation sequencing in clinical practice has contributed to the accumulation of a large number of genomic findings associated with targeted therapy; therefore, the problem of ranking the detected findings has become acute. The European Society for Medical Oncology Scale of Clinical Actionability of molecular Targets (ESCAT) system was designed by the European Society for Medical Oncology to rank biomarkers into levels of evidence that reflect their potency and clinical significance based on published clinical data. However, the ESCAT system remains imperfect, as it is based on a subjective assessment of the levels of evidence.

View Article and Find Full Text PDF

Dendritic cells (DCs) within the tumor microenvironment (TME) have an insufficient capacity to activate T cells through antigen presentation. Furthermore, the programmed cell-death ligand 1 (PD-L1), abundantly expressed on tumor-associated DCs, binds the programmed cell-death 1 (PD-1)-positive T cells and suppresses their immune function. The binding of PD-L1 to CD80 (B7.

View Article and Find Full Text PDF

Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration.

Int J Antimicrob Agents

November 2024

Laboratory of Pathogen Population Variability Mechanisms, N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia. Electronic address:

Pharmacokinetics and safety studies of innovative drugs is an essential part of drug development process. Previously we have developed a novel drug for intravenous administration (lyophilizate) containing modified endolysin LysECD7-SMAP that showed notable antibacterial effect in different animal models of systemic infections. Here we present data on pharmacokinetics of endolysin in mice after single and multiple injections.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!